JPWO2023021492A5 - - Google Patents
Info
- Publication number
- JPWO2023021492A5 JPWO2023021492A5 JP2024509422A JP2024509422A JPWO2023021492A5 JP WO2023021492 A5 JPWO2023021492 A5 JP WO2023021492A5 JP 2024509422 A JP2024509422 A JP 2024509422A JP 2024509422 A JP2024509422 A JP 2024509422A JP WO2023021492 A5 JPWO2023021492 A5 JP WO2023021492A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclosporine
- mixture
- temperature
- stable
- ophthalmic formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121037917 | 2021-08-20 | ||
| IN202121037917 | 2021-08-20 | ||
| PCT/IB2022/057851 WO2023021492A1 (en) | 2021-08-20 | 2022-08-22 | Stable cyclosporine ophthalmic formulation and manufacturing process thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024530245A JP2024530245A (ja) | 2024-08-16 |
| JPWO2023021492A5 true JPWO2023021492A5 (https=) | 2025-09-05 |
| JP2024530245A5 JP2024530245A5 (https=) | 2025-09-05 |
Family
ID=78468801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509421A Pending JP2024530244A (ja) | 2021-08-20 | 2021-10-06 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
| JP2024509422A Pending JP2024530245A (ja) | 2021-08-20 | 2022-08-22 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509421A Pending JP2024530244A (ja) | 2021-08-20 | 2021-10-06 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240342086A1 (https=) |
| EP (2) | EP4387589A4 (https=) |
| JP (2) | JP2024530244A (https=) |
| CN (2) | CN117957011A (https=) |
| AU (2) | AU2021267217A1 (https=) |
| IL (2) | IL310823A (https=) |
| MX (2) | MX2024002234A (https=) |
| WO (2) | WO2021224901A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4719350A1 (en) * | 2023-05-29 | 2026-04-08 | Sun Pharmaceutical Industries Limited | Stable cyclosporine ophthalmic formulation and manufacturing process thereof |
| WO2025163677A1 (en) * | 2024-01-31 | 2025-08-07 | Registrar, Panjab University, Chandigarh | Nanomicellar composition for high permeation and extended-release drug delivery system |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836946C (en) * | 2011-05-27 | 2017-08-01 | Allergan, Inc. | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| PL2887923T3 (pl) * | 2012-08-24 | 2023-08-14 | Sun Pharmaceutical Industries Limited | Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu |
| US20200237859A1 (en) * | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
| EP3373976B1 (en) * | 2015-11-10 | 2024-01-03 | Sun Pharmaceutical Industries Limited | Topical formulations and uses thereof |
| US10918694B2 (en) * | 2016-02-29 | 2021-02-16 | Sun Pharma Global Fze | Topical cyclosporine-containing formulations and uses thereof |
-
2021
- 2021-10-06 WO PCT/IB2021/059176 patent/WO2021224901A2/en not_active Ceased
- 2021-10-06 JP JP2024509421A patent/JP2024530244A/ja active Pending
- 2021-10-06 US US18/683,943 patent/US20240342086A1/en active Pending
- 2021-10-06 CN CN202180102266.5A patent/CN117957011A/zh active Pending
- 2021-10-06 AU AU2021267217A patent/AU2021267217A1/en active Pending
- 2021-10-06 EP EP21800075.0A patent/EP4387589A4/en active Pending
- 2021-10-06 IL IL310823A patent/IL310823A/en unknown
- 2021-10-06 MX MX2024002234A patent/MX2024002234A/es unknown
-
2022
- 2022-08-22 US US18/683,932 patent/US20240423912A1/en active Pending
- 2022-08-22 CN CN202280007116.0A patent/CN116528838A/zh active Pending
- 2022-08-22 IL IL310887A patent/IL310887A/en unknown
- 2022-08-22 JP JP2024509422A patent/JP2024530245A/ja active Pending
- 2022-08-22 AU AU2022330409A patent/AU2022330409A1/en active Pending
- 2022-08-22 EP EP22768958.5A patent/EP4387591A1/en active Pending
- 2022-08-22 WO PCT/IB2022/057851 patent/WO2023021492A1/en not_active Ceased
- 2022-08-22 MX MX2024002235A patent/MX2024002235A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1158994C (zh) | 含环丙沙星和地塞米松的局部悬浮制剂 | |
| TWI692364B (zh) | 含有迪夸弗索之點眼液 | |
| EP0298740A1 (en) | Pediatric ibuprofen compositions | |
| NO174916B (no) | Fremgangsmåte for fremstilling av et medikament for behandling av öyenbetennelser | |
| JPH03133925A (ja) | コラーゲン含有眼科用製剤 | |
| JP2011093923A (ja) | 点眼剤 | |
| JPH0333128B2 (https=) | ||
| JPH10507162A (ja) | ７−ハロ−１，２，３，４−テトラヒドロ−３−アリール−６−キナゾリン スルホンアミドを含有する非経口溶液 | |
| JP3131693B2 (ja) | 眼疾患を処置するための５―メチル―イソオキサゾール―４―カルボン酸アニリド類または２―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物 | |
| JPWO2023021492A5 (https=) | ||
| JPWO2020139525A5 (https=) | ||
| IL310887A (en) | Stable cyclosporine ophthalmic formulation and its manufacturing process | |
| JPWO2001087304A1 (ja) | 点眼剤 | |
| EP0003682B1 (en) | Process for solubilizing an insoluble drug and an aqueous solution prepared by this process | |
| JP5500162B2 (ja) | 点眼剤 | |
| JPH0662417B2 (ja) | 抗アレルギー点眼液 | |
| JP4294276B2 (ja) | 点眼剤組成物 | |
| EP1305033B1 (en) | Pharmaceutical compositions containing tobramycin and xanthan gum | |
| JPWO2021224901A5 (https=) | ||
| JP2002518348A (ja) | プロスタグランジンおよびベンジルアルコールを含む液剤 | |
| JP4961671B2 (ja) | 点眼剤 | |
| JP4183750B2 (ja) | ファムシクロビル一水化物 | |
| JP4779382B2 (ja) | 点眼剤用組成物 | |
| JP2004026695A (ja) | 水性点眼用製剤 | |
| JP2004359548A (ja) | アシクロビル含有水溶液製剤 |